EGFR TKI resistance in lung cancer cells using RNA sequencing and analytical bioinformatics tools-Reference-Cited by-同舟云学术

EGFR TKI resistance in lung cancer cells using RNA sequencing and analytical bioinformatics tools

Published:2022-12-16 Issue: Volume: Page:1-20
ISSN:0739-1102
Container-title:Journal of Biomolecular Structure and Dynamics
language:en
Short-container-title:Journal of Biomolecular Structure and Dynamics

Author:

Howell Jr. Mark C.¹²,Green Ryan¹²,Cianne Junior¹,Dayhoff Guy W.³,Uversky Vladimir N.¹^ORCID,Mohapatra Shyam²⁴,Mohapatra Subhra¹⁴^ORCID

Affiliation:

1. Department of Molecular Medicine, University of South Florida, Tampa, FL, USA

2. Center for Research & Education in Nanobioengineering, Division of Translational Medicine, Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, USA

3. Department of Chemistry, College of Art and Sciences, University of South Florida, Tampa, FL, USA

4. James A. Haley Veterans Hospital, Tampa, FL, USA

Funder

National Institutes of Health

u.s. department of veterans affairs

Publisher

Informa UK Limited

Subject

Molecular Biology,General Medicine,Structural Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/07391102.2022.2153269

Reference99 articles.

1. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update

2. The Impact of Smoking and TP53 Mutations in Lung Adenocarcinoma Patients with Targetable Mutations—The Lung Cancer Mutation Consortium (LCMC2)

3. Local and Systemic Recurrence is the Achilles Heel of Cancer Surgery

4. Turning the tide in lung cancer

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of Inadequate Exposure to Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors on the Development of Resistance in Non-Small-Cell Lung Cancer Cells;International Journal of Molecular Sciences;2024-04-29

2. DUSP1 Promotes Osimertinib Drug-Tolerant Persistence by Inhibiting MAPK/ERK Signaling in Non-small Cell Lung Cancer;Molecular Biotechnology;2024-03-29

3. Utility of patient-derived xenografts to evaluate drug sensitivity and select optimal treatments for individual non-small-cell lung cancer patients;2024-01-19

4. Precision targeted therapy for EGFR mutation‐positive NSCLC: Dilemmas and coping strategies;Thoracic Cancer;2023-04-02